FIELD: chemistry.
SUBSTANCE: invention relates to the user of 5-alkyl-3-(pyrid-3-yl)isoxazoles and 4,5-dihydro-derivatives thereof of general formula
where for 5-alkyl-3-(pyrid-3-yl)isoxazoles, R1 is CH3, C3H7, C4H9, C7H15, C8H17, and for 4,5-dihydro-derivatives R1 is CH3, C8H17, C16H33, as agents having anti-aggregation activity.
EFFECT: use of 5-alkyl-3-(pyrid-3-yl)isoxazoles and 4,5-dihydro-derivatives thereof as anti-aggregation agents.
3 dwg, 5 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOXAZOLE DERIVATIVES HAVING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2726127C1 |
| SUBSTITUTED N-[OMEGA-AZOL-1-YL)ALKYL]BENZOLSULFAMIDES, METHODS OF OBTAINING THEM AND THEIR APPLICATION AS ANTIAGREGANTS | 2006 |
|
RU2339625C2 |
| SUBSTITUTED ω-AZOLYLALKANE ANILIDES, METHOD FOR THEIR PREPARING AND USING AS ANTI-AGGREGATING AGENT | 2006 |
|
RU2322440C1 |
| ANTIAGGREGATING AGENTS | 1993 |
|
RU2088229C1 |
| 3-METHYL-8-PIPERAZINE-7-(THIETHANYL-3)-1-ETHYLXANTHINE HYDROCHLORIDE, EXHIBITING ANTIAGGREGANT AND DISAGGREGATION ACTIVITY | 2009 |
|
RU2404181C1 |
| SUBSTITUTED O-[ω-(AZOL-1-YL)ALKYL]-N-PHENYLCARBAMATES AS AGENTS WITH ANTIAGGREGATORY ACTIVITY, METHOD FOR PRODUCTION THEREOF (VERSIONS) AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2009 |
|
RU2488583C2 |
| 5-(4'-HYDROXYPHENYL)-AND 5-(2',5'-DIHYDROXYPHENYL)-6 H-1,3,4-THIADIAZINE-2-AMINES, HYDROHALOGENIDES INHIBITING THROMBOCYTE AGGREGATION IN INTRAVENOUS INTRODUCTION | 2009 |
|
RU2458060C2 |
| HYDROCHLORIDES OF 1-ALKYL-3-METHYL-8-PIPERAZINO-7-(TIETHANYL-3)XANTHINE SHOWING ANTITHROMBOTIC EFFECT BY BLOCKING GP IIb-IIIa PLATELETS RECEPTORS | 2017 |
|
RU2640579C1 |
| 2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
| METHOD OF INTENSIFYING ANTIAGGREGANT ACTIVITY | 2010 |
|
RU2440370C2 |
